What if relief from treatment-resistant depression, anxiety, or PTSD was already FDA-approved, accessible from home, and working on your brain in ways traditional medications can't?

In this episode, we sit down with Sharon Niv, co-founder of Joyous — the at-home microdose ketamine program changing how people approach mental health treatment. We cover the neuroscience, real-world outcomes, how dosing and program length actually work, medication compatibility, the debate around therapy-assisted versus unassisted ketamine, what therapists need to know about training and integration, and — Alicia's favorite part of the whole conversation — what low-dose ketamine reveals about consciousness itself.

This one is for the clinicians, the skeptics, and the people curious of what they are actually capable of- link to the work below.

🔗 joyous.team